Changeflow GovPing Pharma & Drug Safety Novel Benzoxazole Derivative Comprising 4-Amino...
Routine Notice Added Final

Novel Benzoxazole Derivative Comprising 4-Amino-Butanamide and Anti-Inflammatory Use

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

USPTO published patent application US20260092043A1 by EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION disclosing novel benzoxazole derivatives comprising 4-amino-butanamide and their anti-inflammatory pharmaceutical applications. The application (No. 19115423) was filed March 14, 2023 and published April 2, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO published patent application US20260092043A1 disclosing novel benzoxazole derivatives incorporating 4-amino-butanamide moieties and their use as anti-inflammatory agents. The application names six inventors: Hyun Ae Woo, Hea Young Park, Da-Rong Kim, Ji-Young Park, Ji Hye Yoo, and Yeon-ju Heo. CPC classifications include C07D 263/58 (heterocyclic compounds), A61K 31/423 (therapeutic preparations), and A61P 29/00 (anti-inflammatory agents). This represents priority research from EWHA University-Industry Collaboration Foundation in South Korea.

Patent applications do not impose compliance obligations on third parties. Pharmaceutical companies and research institutions conducting anti-inflammatory drug development should review the published claims to assess potential freedom-to-operate implications or licensing opportunities. Competitors developing benzoxazole-based anti-inflammatory compounds should conduct prior art searches to evaluate patent landscape and potential design-around needs.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

NOVEL BENZOXAZOLE DERIVATIVE COMPRISING 4-AMINO-BUTANAMIDE AND USE THEREOF

Application US20260092043A1 Kind: A1 Apr 02, 2026

Assignee

EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION

Inventors

Hyun Ae WOO, Hea Young PARK, Da-Rong KIM, Ji-Young PARK, Ji Hye YOO, Yeon-ju HEO

Abstract

The present disclosure relates to novel benzoxazole derivatives comprising 4-amino-butanamide and anti-inflammatory use thereof.

CPC Classifications

C07D 263/58 A61K 31/423 A61P 29/00

Filing Date

2023-03-14

Application No.

19115423

View original document →

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260092043A1

Who this affects

Applies to
Pharmaceutical companies Research institutions Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 5416 Management Consulting 6211 Healthcare Providers
Activity scope
Pharmaceutical Patent Filing Anti-inflammatory Drug Research Heterocyclic Compound Development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!